El 14 y 15 de diciembre se van a realizar en Sevilla las VIII Jornadas Monográficas de la SEV. Organizadas por nuestra compañera de la SEV, Mª Ángeles Muñoz-Fernández tratarán sobre "Inflamación sistémica e infecciones virales".
¡Os animos a asistir!
El jueves 1 de diciembre se celebrará la II Jornada UCM-SEV de sensibilización del VIH/SIDA en la Facultad de Veterinaria de la Universidad Complutense de Madrid, organizada por alumnos del Máster en Virología UCM.
La inscripción es gratuita en: sev.virologia@gmail.com. Se entregará certificado de asistencia.
¡Os esperamos!
XVI Jornadas sobre Prevención y Tratamiento de la Infección por VIH en Recién Nacidos y Niños. VII curso de la cohorte nacional pediátrica CoRISpe
Lunes 28 de noviembre de 2016 en el Hospital Gregorio Marañón (inscripción gratuita).
Network Opportunities for Sharing – June 2016
Over the recent years, drug discovery via high throughput screening (HTS) has moved beyond the boundaries of pharmaceutical companies and been successfully integrated into research programs of many academic institutes. These efforts have taken advantage of the availability of diverse libraries of small molecules, either as pure entities or natural product extracts. However, identification of candidate drugs benefits from an in-depth understanding of potential pitfalls of HTS, which can include (i), storage of compound libraries (ii), stability and cost of assay reagents (iii), robustness of the assay and (iv), access to bioinformatics to analyze the wealth of data that results ...
“1st Advanced Course in Clinical and Molecular Virology” to be held in Porto (Portugal) between 9-20th May 2016. The two week course was designed to promote the state of the art knowledge in the field of Virology.
On behalf of the Coorganizers Gabriella Campadelli-Fiume, Thomas Mertens, Giorgio Palù, and Dana Wolf, please find attached the announcement of the 4th European Seminar in Virology on Oncogenic and Oncolytic Viruses, with the deadline for abstract submission (April 15).
IMI* has put out a call for research and innovation proposals to advance its programme on Ebola and other filoviral haemorrhagic fevers (Ebola+). This call is continuously open for a period of two years with the following submission cut-off dates: 16 March 2016, 15 September 2016, 16 March 2017, 14 September 2017, and 15 March 2018. For more information click here: http://www.imi.europa.eu/content/imi-2-call-8.
*The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. It supports collaborative research projects and builds networks ...